Avid Bioservices, Inc. CDMO

Full chart Compare
Set alert

Price alert · CDMO

All alert types
12.49 0.00 (+0.00%)

At closeFeb 4, 2025, 4:00 PM EST

12.49 Day range 12.49

52-week range unavailable

YTD
+1.13%
1 year
+55.16%

Revenue & Expenses

Revenue → Gross Profit: $7.32MGross Profit → Expenses: $7.32MRevenue → Cost of Revenue: $132.59MExpenses → Selling, General & Admin: $26.00MExpenses → Interest Expense: $4.34MExpenses → Other Expenses: $3.91MExpenses → Income Tax: $113.83MNet Loss → Expenses: $140.75MGross Profit$7.32MNet Loss$140.75MCost of Revenue$132.59MExpenses$148.07MSelling, General & Admin$26.00MInterest Expense$4.34MOther Expenses$3.91MIncome Tax$113.83MRevenue$139.91M

Latest period ending Apr 30, 2024 · select a line to chart its full history

CDMO annual income statement
Fiscal yearFY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022FY 2021 Apr 30, 2021FY 2020 Apr 30, 2020
139.91M149.27M119.60M95.87M59.70M
7.32M31.48M36.65M29.31M3.93M
-18.68M3.60M15.42M12.24M-10.94M
-140.75M259.00K127.67M11.21M-10.47M
-2.23—1.840.06-0.27
CDMO annual balance sheet
Fiscal yearFY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022FY 2021 Apr 30, 2021FY 2020 Apr 30, 2020
38.11M38.89M126.52M170.26M36.61M
336.56M451.57M429.84M265.51M107.62M
275.67M262.40M255.32M187.77M65.72M
206.38M189.23M182.53M118.19M26.85M
60.89M189.17M174.53M77.74M41.90M
CDMO annual cash flow
Fiscal yearFY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022FY 2021 Apr 30, 2021FY 2020 Apr 30, 2020
10.95M-12.72M9.46M31.18M5.83M
-31.80M-77.80M-56.41M-9.86M-3.81M
20.07M2.90M3.20M112.33M1.10M
-31.80M-77.80M-56.41M-9.86M-3.81M
-786.00K-87.62M-43.75M133.65M3.11M